Parasol Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Parasol Investment Management's PFE Position: Q1 2017 in Review
Parasol Investment Management reduced its Pfizer (PFE) stake by 56% in Q1 2017, selling an estimated $167K and leaving 4,084 shares worth $133K. The position accounts for 0.22% of the portfolio, ranked #36.
Parasol Investment Management first reported a position in PFE in Q4 2013 and has held it in 14 quarters since. The position peaked at $567K in Q2 2014. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.
- Parasol Investment Management held 4,084 shares of Pfizer worth $133K as of Q1 2017.
- Parasol Investment Management sold 5,281 Pfizer shares in Q1 2017, an estimated $167K.
- Pfizer made up 0.22% of Parasol Investment Management's portfolio in Q1 2017, its #36 holding.
- Parasol Investment Management first reported a position in Pfizer in Q4 2013 and has held it in 14 quarters since.
- Parasol Investment Management's Pfizer position peaked at $567K in Q2 2014.
- 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.
Based on Parasol Investment Management's 13F filing for Q1 2017, filed 24 Apr 2017.